Your browser doesn't support javascript.
loading
Congenital Rubella Syndrome in The African Region - Data from Sentinel Surveillance.
Masresha, Balcha; Shibeshi, Messeret; Kaiser, Reinhard; Luce, Richard; Katsande, Regis; Mihigo, Richard.
Afiliação
  • Masresha B; WHO Regional Office for Africa. Brazzaville, Congo.
  • Shibeshi M; WHO Inter-country Support Team for East and Southern Africa. Harare, Zimbabwe.
  • Kaiser R; Formerly with the WHO Inter-country Support Team for East and Southern Africa. Harare, Zimbabwe.
  • Luce R; WHO Inter-country Support Team for Central Africa. Libreville, Gabon.
  • Katsande R; WHO Regional Office for Africa. Brazzaville, Congo.
  • Mihigo R; WHO Regional Office for Africa. Brazzaville, Congo.
J Immunol Sci ; Suppl: 146-150, 2018 Aug 02.
Article em En | MEDLINE | ID: mdl-30957103
ABSTRACT

INTRODUCTION:

Rubella is a mild febrile rash illness caused by the rubella virus. The most serious consequence of rubella is congenital rubella syndrome (CRS), which occurs if the primary rubella infection occurs during early pregnancy, with subsequent infection of the placenta and the developing fetus.

METHODS:

WHO supported countries to set up sentinel surveillance for CRS using standard case definitions, protocols, and case classification scheme. This descriptive analysis summarises the data from 5 countries which have been regularly reporting.

RESULTS:

A total of 383 suspected cases of CRS were notified from the 5 countries as of December 2016, of which 52 cases were laboratory confirmed and 67 were confirmed on clinical grounds.The majority (43%) of confirmed CRS cases were in the age group 6 - 11 months. The most common major clinical manifestation (Group A) among the confirmed cases is congenital heart disease (72%) followed by cataracts (32%) and glaucoma (10%). DISCUSSION AND

CONCLUSIONS:

The number of years of reporting from these sentinel sites is too short to describe trends in CRS occurrence across the years. However, the limited surveillance data has yielded comparable information with other developing countries prior to introduction of rubella vaccine. As more countries introduce rubella vaccine into their immunisation programs, there is a need to ensure that all rubella outbreaks are thoroughly investigated and documented, to expand sentinel surveillance for CRS in more countries in the Region, and to complement this with retrospective record reviews for CRS cases in selected countries.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Congo

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Congo